Chebel, Amel <br/><br/>
Indirubin derivatives inhibit malignant lymphoid cell proliferation.  [electronic resource] 

 -  Leukemia & lymphoma  Dec 2009 
 - 2049-60 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1029-2403 
<br/><br/><label>Standard No.: </label>10.3109/10428190903288449  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibiotics, Antineoplastic--pharmacology<br/>Apoptosis--drug effects<br/>Autophagy--drug effects<br/>Blotting, Western<br/>Cell Cycle--drug effects<br/>Cell Cycle Proteins--metabolism<br/>Cell Line<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Cyclin E--metabolism<br/>Cyclin-Dependent Kinase 6--metabolism<br/>Cyclin-Dependent Kinase Inhibitor p21--metabolism<br/>Cyclin-Dependent Kinase Inhibitor p27<br/>Dose-Response Relationship, Drug<br/>Flow Cytometry<br/>Humans<br/>Indoles--pharmacology<br/>Intracellular Signaling Peptides and Proteins--metabolism<br/>Jurkat Cells<br/>Lymphocytes--drug effects<br/>Oximes--pharmacology<br/>Time Factors